SCP-8181
Unknown
~
medium confidence
SCP-8181
Expected annual
$73.5M
One-time setup
$34.3M
Annual recurring
$68.8M
Personnel
22
Initial capital procurement for specialized antimemetic/thaumatological hardware and secured facilities dominates one-time costs (~$34M), while ongoing R&D, antimemetic programs and legal/cover operations drive recurring annual costs (~$68.8M). Major-breach scenarios can add hundreds of millions in emergency spending.
One-Time Capital Costs
Total: $34.3M
Annual Recurring Costs
Total: $68.8M/yr
Cost Scenarios
📊
Baseline
(baseline)
$68.8M/yr
Normal, uneventful operational year with no major incidents; routine R&D, maintenance, staffing and cover operations only.
no breach
stable containment
routine operations
🚨
Minor Incident
$73.8M/yr
Localized containment incident requiring rapid-response TF activation, targeted amnestic deployments, limited repairs and PR/cover operations.
localized breach
small-scale memetic leak
targeted amnestic campaign
🚨
Major Breach
$268.8M/yr
Large-scale breach or Hyperway failure requiring mass amnesticization, multinational TF deployment, anchor replacement and major reconstruction/recovery.
anchor failure
mass public exposure
cross-dimensional incursion
Personnel
22 total
| Role | Count | Notes |
|---|---|---|
| Research Scientist / Thaumatologist | 8 | [#3] Full-time thaumatologists/ritualists forming a continuous maintenance cell (rotating shifts); headcount estimated from the example 6–12 specialist cell. |
| Security Officer / MTF Agent | 12 | [#4] Task Force and security personnel administering SCP-8181-KEY and perimeter/escort duties; roster sized for 24/7 coverage. |
| Administrative Staff | 2 | [#3, #4] On-site administrative/operations coordinators included in payroll estimates to support scheduling, procurement and liaison duties. |
Confidence Notes
Estimates derive from broad ranges supplied in analyst notes; many line items have order-of-magnitude uncertainty (number of sites, anchors, and frequency/severity of breaches). Budgeting for reserves and R&D dominates uncertainty.